Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gary Lyman and Nicole Kuderer.
Gary Lyman
Connection Strength
8.937
Nicole Kuderer
  1. Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma. Cancer Invest. 2021 Jul-Aug; 39(6-7):449-456.
    View in: PubMed
    Score: 0.955
  2. Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer. Cancer Invest. 2021 Mar; 39(3):205-213.
    View in: PubMed
    Score: 0.930
  3. Challenges of Cancer Immunotherapy during the COVID-19 Pandemic. Cancer Invest. 2021 02; 39(2):115-119.
    View in: PubMed
    Score: 0.921
  4. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative. Cancer Invest. 2020 11; 38(10):537-542.
    View in: PubMed
    Score: 0.912
  5. COVID-19, Cancer, and Consequences: Where Are We Now? Cancer Invest. 2020 Sep; 38(8-9):431-435.
    View in: PubMed
    Score: 0.903
  6. Personalized cancer supportive care in COVID-19 era. Ann Oncol. 2020 07; 31(7):835-837.
    View in: PubMed
    Score: 0.882
  7. Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety. J Clin Oncol. 2018 06 20; 36(18):1773-1776.
    View in: PubMed
    Score: 0.767
  8. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018 04; 164 Suppl 1:S112-S118.
    View in: PubMed
    Score: 0.761
  9. Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era. Front Oncol. 2021; 11:697908.
    View in: PubMed
    Score: 0.239
  10. Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open. 2021 02; 6(1):100038.
    View in: PubMed
    Score: 0.230
  11. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918.
    View in: PubMed
    Score: 0.221
  12. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK). Oncologist. 2018 02; 23(2):247-255.
    View in: PubMed
    Score: 0.184
  13. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Thromb Haemost. 2017 11 01; 117(11):2135-2145.
    View in: PubMed
    Score: 0.184
  14. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial. Thromb Res. 2017 Mar; 151:89-95.
    View in: PubMed
    Score: 0.175
  15. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10; 31(17):2189-204.
    View in: PubMed
    Score: 0.136
  16. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532.
    View in: PubMed
    Score: 0.060
  17. Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer Invest. 2021 Apr; 39(4):315-320.
    View in: PubMed
    Score: 0.059
  18. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 06; 32(6):787-800.
    View in: PubMed
    Score: 0.058
  19. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies. Cancer. 2021 05 01; 127(9):1459-1468.
    View in: PubMed
    Score: 0.058
  20. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer Discov. 2020 10; 10(10):1514-1527.
    View in: PubMed
    Score: 0.056
  21. Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020; 1(5):473-476.
    View in: PubMed
    Score: 0.055
  22. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728.
    View in: PubMed
    Score: 0.051
  23. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2019 Mar; 27(3):921-925.
    View in: PubMed
    Score: 0.049
  24. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2018 02; 16(2):279-292.
    View in: PubMed
    Score: 0.047
  25. Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study. JNCI Cancer Spectr. 2017 Sep; 1(1):pkx009.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.